{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:43:57Z","timestamp":1791852237974,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.bbagen.2011.03.015","type":"journal-article","created":{"date-parts":[[2011,4,2]],"date-time":"2011-04-02T16:59:22Z","timestamp":1301763562000},"page":"619-624","source":"Crossref","is-referenced-by-count":259,"title":["MELAS: A nationwide prospective cohort study of 96 patients in Japan"],"prefix":"10.1016","volume":"1820","author":[{"given":"Shuichi","family":"Yatsuga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataliya","family":"Povalko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Nishioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koju","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Kakimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyojiro","family":"Matsuishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuyuki","family":"Kakuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutoshi","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2011.03.015_bb0005","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nrg1606","article-title":"Mitochondrial DNA mutations in human disease","volume":"6","author":"Taylor","year":"2005","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbagen.2011.03.015_bb0010","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ana.410160409","article-title":"Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke like episodes: a distinctive clinical syndrome","volume":"16","author":"Pavlakis","year":"1984","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbagen.2011.03.015_bb0015","unstructured":"S. DiMauro and M. Hirano. MELAS, R.A. Pagon, T.C. Bird, C.R. Dolan, K. Stephens and editors, Seattle (WA), University of Washington Seattle, Gene reviews [Internet; http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1233\/] (1993), updated 2010 Oct 14."},{"key":"10.1016\/j.bbagen.2011.03.015_bb0020","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/348651a0","article-title":"A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies","volume":"348","author":"Goto","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2011.03.015_bb0025","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1212\/WNL.42.3.545","article-title":"Mitochondrial myopathy, encephalopathy, lactic acidosis, andstrokelike episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation","volume":"42","author":"Goto","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.bbagen.2011.03.015_bb0030","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1002\/mus.880181425","article-title":"Maternally inherited diabetes and deafness (MIDD): a distinct subform of diabetes associated with a mitochondrial tRNA(Leu)(UUR) gene point mutation","volume":"3","author":"van den Ouweland","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bbagen.2011.03.015_bb0035","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/088307389400900102","article-title":"Mitochondrial myopathy, encephalopathy, lactic acidosis, andstrokelike episodes (MELAS): current concepts","volume":"9","author":"Hirano","year":"1994","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.bbagen.2011.03.015_bb0040","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1196\/annals.1444.011","article-title":"Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes, basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome","volume":"1143","author":"Sproul","year":"2008","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.bbagen.2011.03.015_bb0045","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0960-8966(03)00097-X","article-title":"116th ENMC international workshop: the treatment of mitochondrial disorders, 14th\u201316th March 2003, Naarden, The Netherlands","volume":"13","author":"Chinnery","year":"2003","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.bbagen.2011.03.015_bb0050","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ana.21217","article-title":"Prevalence of mitochondrial DNA disease in adults","volume":"63","author":"Schaefer","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbagen.2011.03.015_bb0055","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bbabio.2004.09.005","article-title":"The epidemiology of mitochondrial disorders\u2014past, present and future","volume":"1659","author":"Schaefer","year":"2004","journal-title":"Bioch. Biophy. Act BBA Bioenerg."},{"key":"10.1016\/j.bbagen.2011.03.015_bb0060","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/1531-8249(200008)48:2<188::AID-ANA8>3.0.CO;2-P","article-title":"The epidemiology of pathogenic mitochondrial DNA mutations","volume":"48","author":"Chinnery","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbagen.2011.03.015_bb0065","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ana.75","article-title":"The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA abnormalities","volume":"49","author":"Darin","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbagen.2011.03.015_bb0070","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/brain\/awg170","article-title":"Minimum birth prevalence of mitochondrial respiratory chain disorders in children","volume":"126","author":"Skladal","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.bbagen.2011.03.015_bb0075","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1023\/B:BOLI.0000031098.41409.55","article-title":"Mitochondrial disorders: prevalence, myths and advances","volume":"27","author":"Thorburn","year":"2004","journal-title":"J. Inher. Metab. Dis."},{"key":"10.1016\/j.bbagen.2011.03.015_bb0080","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ajhg.2008.07.004","article-title":"Pathogenic mitochondrial DNA mutations are common in the general population","volume":"83","author":"Elliott","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbagen.2011.03.015_bb0085","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ajmg.1426","article-title":"Epidemiology and treatment of mitochondrial disorders","volume":"106","author":"Chinnery","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbagen.2011.03.015_bb0090","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1086\/301959","article-title":"Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population","volume":"63","author":"Majamaa","year":"1998","journal-title":"Am. J. Hum. Gen."},{"key":"10.1016\/j.bbagen.2011.03.015_bb0095","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ana.21196","article-title":"Prevalence, segregation, and phenotype of the mitochondrial DNA 3243A>G mutation in children","volume":"62","author":"Uusimaa","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbagen.2011.03.015_bb0100","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.mito.2006.12.004","article-title":"Population prevalence of the MELAS A3243G mutation","volume":"7","author":"Manwaring","year":"2007","journal-title":"Mitochondrion"},{"key":"10.1016\/j.bbagen.2011.03.015_bb0105","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/adc.82.5.407","article-title":"Heterogeneous presentation in A3243G mutation in the mitochondrial tRNALeu(UUR) gene","volume":"82","author":"Koga","year":"2000","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.bbagen.2011.03.015_bb0110","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/archneurol.2008.526","article-title":"Protean phenotypic features of the A3243G mitochondrial DNA mutation","volume":"66","author":"Kaufmann","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbagen.2011.03.015_bb0115","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0960-8966(92)90045-8","article-title":"Melas: an original case and clinical criteria for diagnosis","volume":"2","author":"Hirano","year":"1992","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.bbagen.2011.03.015_bb0120","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1001\/archneur.64.11.1625","article-title":"Wolff\u2013Parkinson\u2013White syndrome in patients with MELAS","volume":"64","author":"Sproule","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbagen.2011.03.015_bb0125","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.nmd.2006.08.006","article-title":"A scale to monitor progression and treatment of mitochondrial disease in children","volume":"16","author":"Phoenix","year":"2006","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.bbagen.2011.03.015_bb0130","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1212\/01.wnl.0000219759.72195.41","article-title":"Mitochondrial disease in adults; A scale to monitor progression and treatment","volume":"66","author":"Scheafer","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bbagen.2011.03.015_bb0135","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1177\/000992280304200806","article-title":"The spectrum of mitochondrial disease in 75 pediatric patients","volume":"42","author":"Skladal","year":"2003","journal-title":"Clin. Pediatr."},{"key":"10.1016\/j.bbagen.2011.03.015_bb0140","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1749-6632.2010.05624.x","article-title":"MELAS and l-arginine therapy: pathophysiology of stroke-like episodes","volume":"1201","author":"Koga","year":"2010","journal-title":"Ann. NY Acad. Sci."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030441651100064X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030441651100064X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T15:22:47Z","timestamp":1543850567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030441651100064X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S030441651100064X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2011.03.015","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}